Most Chinese Unwilling To Try Unreasonably Low-priced Drugs
This article was originally published in PharmAsia News
An online survey conducted by health.sohu.com shows that 69 percent of respondents believe exceptionally low-priced drugs have quality problems, and 84 percent would not try them
You may also be interested in...
Experts think GLP-1s in neurodegeneration may be Novo Nordisk’s next opportunity and await readouts from the Phase II ELAD trial in Alzheimer's disease for signals.
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.